IL6 and endothelial dysfunction: Elevated interleukin-6 (IL-6) and activated nuclear factor-kappa B (NF-κB) alter vascular homeostasis by increasing vascular permeability, enhancing monocyte adhesion, and promoting smooth muscle cell proliferation, contributing to endothelial dysfunction and plaque formation.